Table 3
Incremental lung cancer-specific survival between low-dose computed tomography screening and control arm, by stage and years survived from diagnosis of non-small-cell lung cancer, Cancer Risk Management Model-Lung Cancer (CRMM-LC) and National Lung Screening Trial (NLST)

Table 3
Incremental lung cancer-specific survival between low-dose computed tomography screening and control arm, by stage and years survived from diagnosis of non-small-cell lung cancer, Cancer Risk Management Model-Lung Cancer (CRMM-LC) and National Lung Screening Trial (NLST)
Table summary
This table displays the results of Incremental lung cancer-specific survival between low-dose computed tomography screening and control arm. The information is grouped by Stage (appearing as row headers), Years survived lung cancer, 0, 1, 2, 3, 4, 5, 6 and 7 (appearing as column headers).
Stage Years survived lung cancer
0 1 2 3 4 5 6 7
Survival improvement due to screening (%)
I  
CRMM-LC 0 6 9 9 9 9 9 9
NLST 0 8 10 11 8 8 13 9
II  
CRMM-LC 0 4 3 1 1 1 1 1
NLST 0 8 10 10 0 0 -3 -3
III  
CRMM-LC 0 6 5 0 0 0 1 1
NLST 0 0 6 0 0 0 0 4
IV  
CRMM-LC 0 4 0 -1 -1 -1 -1 -1
NLST 0 2 2 1 1 3 2 1
Date modified: